Brief: Molecure Says US IRB Okays Second Phase Of Study For OATD-01

Molecure SA

05/09/2023 14:26

Sept 5 (Reuters) - Molecure SA  MOCP.WA :
    * US INSTITUTIONAL REVIEW BOARD (IRB) OKAYS SECOND PHASE OF
CLINICAL STUDY FOR OATD-01
    * SEES FIRST PATIENT TO ENTER STUDY IN Q4
    * TOTAL OF 90 PATIENT TO PARTICIPATE IN STUDY

Source text for Eikon:  ID:nEM49jxvqa 
Further company coverage:  MOCP.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))